In Yet Another Sign That Psychedelics Are Making Their Way Into the Mainstream, Compass Pathways, a UK-Based Psychedelics Startup Focused on Producing Psilocybin, Has Filed for its Initial Public Offering... read more →
After Years of Circling the Industry Looking For Signs to Invest, and While Watching the Growing Need for Opioid-Free Mental Health Treatment, Investors Are Now Beginning to See Psychedelics as... read more →
ATAI Life Sciences Will Use the Proceeds from its $24 Million Convertible Note Financing to Explore the Effects of Psychedelic Medicine on Mental Health A New Group of Renowned Investors... read more →
